{"id":201035,"date":"2026-08-13T11:35:22","date_gmt":"2026-08-13T06:05:22","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=201035"},"modified":"2026-08-13T11:35:24","modified_gmt":"2026-08-13T06:05:24","slug":"bayer-cropscience-india-vs-rallis-india","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bayer-cropscience-india-vs-rallis-india\/","title":{"rendered":"Bayer CropScience India vs Rallis India: Share Price, PE and ROE Compared"},"content":{"rendered":"
<\/div>\n

Bayer CropScience India MCap Rs 18,473 Cr, PE 30.64x, ROE 23.24%, Div 3.65%. Rallis India MCap Rs 4,071 Cr, PE 28.15x, ROE 8.75%.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Bayer CropScience India and Rallis India are both listed crop protection companies. Bayer at Rs 18,473 Cr is about 4.5 times larger than Rallis at Rs 4,071 Cr. Bayer has a strong ROE of 23.24% with a high dividend yield of 3.65%. Rallis, the Tata Group agrochemical company, has ROE of 8.75%. Bayer’s profitability and income characteristics are standout in this comparison.<\/p>\n<\/div>\n

The Bayer CropScience India vs Rallis India question comes up often among investors who follow the Crop protection space in India. Bayer CropScience India MCap Rs 18,473 Cr, PE 30. 64x, ROE 23. This article goes through what each company does, their latest financial performance, and the key numbers that matter for anyone evaluating Bayer CropScience India vs Rallis India as a research exercise.<\/p>\n

All data cited here is sourced from publicly available company filings. Verify the latest prices and fundamentals on NSE or BSE before acting on any information.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n